Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...
Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis, with a ...
Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse ...
The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...
The company is evaluating whether the drug, which targets cardiac complications, might be used treat patients with other ...
Among the total systemic sclerosis cohort, 14% of individuals were categorized as frail and 53% as prefrail, with frailty status linked to an increased risk for mortality.
Because it is rare (the incidence rate for the systemic form is estimated to be 19 new cases per year per 1 million adults), many nurses and physicians have only read about scleroderma.
The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...
Amgen’s mysterious obesity asset will remain a mystery for a bit longer—the FDA has put the candidate’s phase 1 trial ...
Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback